Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence
File version
Author(s)
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
An association between non-opioid analgesic agents and chronic kidney disease has long been suspected. The presumed development of chronic renal impairment following protracted excessive use of non-opioid analgesia is known as analgesic nephropathy. Many accept analgesic nephropathy as a real entity despite a paucity of robust scientific evidence. The weight of available observational literature suggests that long-term ingestion of paracetamol and combination mixtures of aspirin and paracetamol probably contribute to chronic renal impairment, however there is no convincing data to implicate non-steroidal anti-inflammatory drugs or aspirin monotherapy. While controversy persists most physicians consider all non-narcotic analgesics nephrotoxic and discourage heavy use where possible.
Journal Title
International Journal of Risk & Safety in Medicine
Conference Title
Book Title
Edition
Volume
28
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Science & Technology
Life Sciences & Biomedicine
Public, Environmental & Occupational Health
General & Internal Medicine
Persistent link to this record
Citation
Yaxley, J, Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence, International Journal of Risk & Safety in Medicine, 2016, 28 (4), pp. 189-196